# Phio Pharmaceuticals Corp.: Form 8-K, filed Mar 27, 2018

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2018-03-27
- Accepted by EDGAR: Mar 27, 2018, 10:11 ET
- Period: 2018-03-27
- Accession: 0001193125-18-096928
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312518096928/d556334d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312518096928/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312518096928/d556334d8k.htm

Filed Mar 27, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-096928. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
